MidCap Financial Investment Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, disclosing a net decrease in net assets from operations of $16.4 million for the third quarter and a net asset value per share of $12.86.
MidCap Financial Investment Corporation filed a Form 8-K on November 5, 2026, announcing its financial results for the quarter ended September 30, 2026, via a press release furnished as Exhibit 99.1.
Lyntris Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting third-quarter revenue of $194,429 thousand and the completion of its initial public offering during the quarter.
Pattern Group Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, reporting third-quarter revenue of $885,847 thousand and nine-month revenue of $2,536,347 thousand.
Traeger, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, and reporting condensed consolidated financial results for the period.
NewLake Capital Partners, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 5, 2026, reporting third-quarter and nine-month financial results for the cannabis-focused real estate investment trust.
Inseego Corp. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the three and nine months ended September 30, 2026, disclosing a third-quarter net loss of $8,103 thousand and a year-to-date net loss of $21,077 thousand.
CION Investment Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting a net decrease in net assets from operations of $3,550 thousand for the third quarter.
SiTime Corporation filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, disclosing share count, risk factors, and financial results for the period.
Haemonetics Corporation filed its quarterly report on Form 10-Q for the fiscal quarter ended September 26, 2026, disclosing revenue, earnings, and balance sheet data for the three and six months ended on that date.